In the general population, risk of cardiovascular disease is inversely associated with HDL-cholesterol levels. However, a new post hoc analysis of data from the German Diabetes Dialysis study reports no correlation between HDL cholesterol and mortality among patients on dialysis—a phenomenon that the authors attribute to HDL dysfunction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Silbernagel, G. et al. HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2013080816.
Vaziri, N. D. Dyslipidemia of chronic renal failure: The nature, mechanisms and potential consequences. Am. J. Physiol. Renal Physiol. 290, F262–F272 (2006).
Vaziri, N. D. Lipotoxicity and impaired high-density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease. J. Renal Nutr. 20, S35–S43 (2010).
Vaziri, N. D., Navab, M. & Fogelman, A. M. HDL metabolism and activity in chronic kidney disease. Nat. Rev. Nephrol. 6, 287–296 (2010).
Holzer, M. et al. Uremia alters HDL composition and function. J. Am. Soc. Nephrol. 22, 1631–1641 (2011).
Shao, B., Oda, M. N., Oram, J. F. & Heinecke, J. W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr. Opin. Cardiol. 21, 322–328 (2006).
Weichhart, T. et al. Serum amyloid A in uremic HDL promotes inflammation. J. Am. Soc. Nephrol. 23, 934–947 (2012).
Yamamoto, S. et al. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J. Am. Coll. Cardiol. 60, 2372–2379 (2012).
Honda, H. et al. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients. Atherosclerosis 220, 493–501 (2012).
Moradi, H. et al. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol. Dial. Transplant. 29, 1554–1562 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Vaziri, N. HDL-cholesterol levels and mortality in patients with ESRD. Nat Rev Nephrol 10, 621–623 (2014). https://doi.org/10.1038/nrneph.2014.169
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2014.169
This article is cited by
-
HDL abnormalities in nephrotic syndrome and chronic kidney disease
Nature Reviews Nephrology (2016)